首页> 外国专利> Charged mesoporous silica nanoparticle-based drug delivery system for controlled release and enhanced bioavailability

Charged mesoporous silica nanoparticle-based drug delivery system for controlled release and enhanced bioavailability

机译:基于带电荷的介孔二氧化硅纳米颗粒的药物递送系统,可控制释放并提高生物利用度

摘要

A charged mesoporous silica nanoparticle (MSN)-based drug delivery system for controlled release and enhanced bioavailability is disclosed. The system comprises a positively charged MSN, which has a silica matrix and an array of pores and/or nanochannels in the matrix. The entire substance of the matrix, all the surfaces and the pores and/or nanochannels comprise a plurality of silanol (Si—OH) and quaternary ammonium functional groups. The bioavailability of a negatively charged bioactive compound can be increased by loading it into the pores and/or nanochannels. The silanol (Si—OH) functional groups on the surfaces lining the walls of the pores and/or nanochannels are free to deprotonate in a fluid having pH above the pI of the positively charged MSN and lead to a sustained release of the negatively charged drug from the pores and/or nanochannels, and thereby enhance the bioavailability of the drug.
机译:公开了用于控制释放和增强的生物利用度的基于带电的介孔二氧化硅纳米颗粒(MSN)的药物递送系统。该系统包括带正电的MSN,MSN具有二氧化硅基质和基质中的一系列孔和/或纳米通道。基质的全部物质,所有表面和孔和/或纳米通道包含多个硅烷醇(Si-OH)和季铵官能团。带负电荷的生物活性化合物的生物利用度可以通过将其装载到孔和/或纳米通道中来增加。在孔和/或纳米通道壁衬里的表面上的硅烷醇(Si-OH)官能团在pH值高于带正电的MSN的液体中自由去质子化并导致带负电的药物的持续释放从孔和/或纳米通道中分离出来,从而提高了药物的生物利用度。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号